GB0622825D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0622825D0
GB0622825D0 GB0622825A GB0622825A GB0622825D0 GB 0622825 D0 GB0622825 D0 GB 0622825D0 GB 0622825 A GB0622825 A GB 0622825A GB 0622825 A GB0622825 A GB 0622825A GB 0622825 D0 GB0622825 D0 GB 0622825D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0622825A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0622825A priority Critical patent/GB0622825D0/en
Publication of GB0622825D0 publication Critical patent/GB0622825D0/en
Priority to BRPI0714062-2A priority patent/BRPI0714062A2/en
Priority to PCT/EP2007/056675 priority patent/WO2008003697A1/en
Priority to CA002655675A priority patent/CA2655675A1/en
Priority to EA200970085A priority patent/EA016076B1/en
Priority to KR1020147001116A priority patent/KR20140016431A/en
Priority to CN2007800330531A priority patent/CN101511787B/en
Priority to PT07787001T priority patent/PT2049478E/en
Priority to AU2007271182A priority patent/AU2007271182B2/en
Priority to DK07787001.2T priority patent/DK2049478T3/en
Priority to ES07787001T priority patent/ES2385505T3/en
Priority to PL07787001T priority patent/PL2049478T3/en
Priority to UAA200900103A priority patent/UA100227C2/en
Priority to SI200730962T priority patent/SI2049478T1/en
Priority to EP07787001A priority patent/EP2049478B1/en
Priority to KR1020097002352A priority patent/KR101398264B1/en
Priority to JP2009517252A priority patent/JP5283620B2/en
Priority to US11/772,977 priority patent/US7718693B2/en
Priority to MX2009000117A priority patent/MX2009000117A/en
Priority to CL2007001949A priority patent/CL2007001949A1/en
Priority to PE2007000855A priority patent/PE20080997A1/en
Priority to TW096124227A priority patent/TW200819127A/en
Priority to ARP070102985A priority patent/AR061815A1/en
Priority to CR10545A priority patent/CR10545A/en
Priority to IL196181A priority patent/IL196181A0/en
Priority to EC2009009028A priority patent/ECSP099028A/en
Priority to NO20090267A priority patent/NO20090267L/en
Priority to MA31599A priority patent/MA30607B1/en
Priority to HK09106719.8A priority patent/HK1127604A1/en
Priority to US12/708,077 priority patent/US8048907B2/en
Priority to HRP20120505TT priority patent/HRP20120505T1/en
Priority to CY20121100671T priority patent/CY1113415T1/en
Priority to CR20140515A priority patent/CR20140515A/en
Ceased legal-status Critical Current

Links

GB0622825A 2006-07-06 2006-11-15 Novel compounds Ceased GB0622825D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0622825A GB0622825D0 (en) 2006-11-15 2006-11-15 Novel compounds
AU2007271182A AU2007271182B2 (en) 2006-07-06 2007-07-03 Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use
JP2009517252A JP5283620B2 (en) 2006-07-06 2007-07-03 Substituted N-phenylmethyl-5-oxo-proline-2-amides as P2X7 receptor antagonists and methods for their use
MX2009000117A MX2009000117A (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use.
CA002655675A CA2655675A1 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
US11/772,977 US7718693B2 (en) 2006-07-06 2007-07-03 Receptor antagonists and their methods of use
KR1020147001116A KR20140016431A (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl-5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
CN2007800330531A CN101511787B (en) 2006-07-06 2007-07-03 Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use
PT07787001T PT2049478E (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
PCT/EP2007/056675 WO2008003697A1 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
DK07787001.2T DK2049478T3 (en) 2006-07-06 2007-07-03 Substituted N-phenylmethyl-5-oxoproline-2-amides as P2X7 receptor antagonists and methods for their use
ES07787001T ES2385505T3 (en) 2006-07-06 2007-07-03 N-Phenylmethyl-5-oxo-proline-2-substituted amides as P2X7 receptor antagonists and methods of use
PL07787001T PL2049478T3 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
UAA200900103A UA100227C2 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl-5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
SI200730962T SI2049478T1 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
EP07787001A EP2049478B1 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
KR1020097002352A KR101398264B1 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl-5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
BRPI0714062-2A BRPI0714062A2 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl-5-oxo-proline-2-amides as p2x receptor antagonists, and their methods of use
EA200970085A EA016076B1 (en) 2006-07-06 2007-07-03 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
CL2007001949A CL2007001949A1 (en) 2006-07-06 2007-07-04 COMPOUNDS DERIVED FROM SUBSTITUTED PROLINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS NEURODEGENERATIVE DISEASES, PAIN AND INFLAMMATION.
ARP070102985A AR061815A1 (en) 2006-07-06 2007-07-04 OXO-PROLINAMIDE COMPOSITE PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
PE2007000855A PE20080997A1 (en) 2006-07-06 2007-07-04 N-PHENYLMETHYL-5-OXO-PROLINA-2-AMIDE COMPOUNDS AS P2X7 RECEPTOR MODULATORS
TW096124227A TW200819127A (en) 2006-07-06 2007-07-04 Novel receptor antagonists and their methods of use
CR10545A CR10545A (en) 2006-07-06 2008-12-19 PROLINAMIDA-2-5-OXO FENILMETIL-N-REPLACED AS ANTAGONIST RECEPTORS AND THEIR METHODS OF USE
IL196181A IL196181A0 (en) 2006-07-06 2008-12-25 Substituted n-phenylmethyl-5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
EC2009009028A ECSP099028A (en) 2006-07-06 2009-01-05 NEW ANTAGONISTS OF RECEPTORS AND THEIR METHODS OF USE
NO20090267A NO20090267L (en) 2006-07-06 2009-01-16 Substituted N-phenylmethyl-5-oxo-proline-2-amides as P2X7 receptor antagonists and their use
MA31599A MA30607B1 (en) 2006-07-06 2009-01-30 SUBSTITUTED N-PHENYLMETHYL -5-OXO-PROLINE-2-AMIDES INSTEAD OF P2X7 RECEPTOR ANTAGONISTS AND METHODS OF USE
HK09106719.8A HK1127604A1 (en) 2006-07-06 2009-07-22 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
US12/708,077 US8048907B2 (en) 2006-07-06 2010-02-18 Receptor antagonists and their methods of use
HRP20120505TT HRP20120505T1 (en) 2006-07-06 2012-06-18 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
CY20121100671T CY1113415T1 (en) 2006-07-06 2012-07-26 Substituted N-phenylmethyl-5-oxo-proline-2-amides as P2X7 receptor antagonists and their methods of use
CR20140515A CR20140515A (en) 2006-07-06 2014-11-10 PROLINAMIDA-2-5-OXO FENILMETIL-N-REPLACED AS ANTAGONIST RECEPTORS AND THEIR METHODS OF USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0622825A GB0622825D0 (en) 2006-11-15 2006-11-15 Novel compounds

Publications (1)

Publication Number Publication Date
GB0622825D0 true GB0622825D0 (en) 2006-12-27

Family

ID=37605368

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0622825A Ceased GB0622825D0 (en) 2006-07-06 2006-11-15 Novel compounds

Country Status (1)

Country Link
GB (1) GB0622825D0 (en)

Similar Documents

Publication Publication Date Title
EP2034838A4 (en) Novel compounds
EP2032142A4 (en) Novel compounds
GB0603550D0 (en) Novel compounds
EP1981900A4 (en) Novel compounds
GB0609962D0 (en) Novel compounds
GB0605462D0 (en) Novel compounds
GB0602900D0 (en) Novel Compounds
GB0609117D0 (en) Novel compounds
GB0609963D0 (en) Novel compounds
EP2031965A4 (en) Novel compounds
GB0607840D0 (en) Novel compounds
GB0600483D0 (en) Novel compounds
GB0609252D0 (en) Novel sytoprotective compounds
GB0608452D0 (en) Novel compounds
GB0607892D0 (en) Novel compounds
GB0605463D0 (en) Novel compounds
GB0607736D0 (en) Novel compounds
GB0602238D0 (en) Novel compounds
GB0603779D0 (en) Novel compounds
GB0603897D0 (en) Novel compounds
GB0603899D0 (en) Novel compounds
GB0603900D0 (en) Novel compounds
GB0604897D0 (en) Novel compounds
GB0602237D0 (en) Novel compounds
GB0622825D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)